Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Hospital-to-Homecare Videoconference Handoff: Improved Communication, Coordination of Care, and Patient/Family Engagement.

Knight SW, Trinkle J, Tschannen D.

Home Healthc Now. 2019 Jul/Aug;37(4):198-207. doi: 10.1097/NHH.0000000000000755.

PMID:
31274582
2.

The Impact of Hospital-Based In Situ Simulation on Nurses' Recognition and Intervention of Patient Deterioration.

Lee C, Mowry JL, Maycock SE, Colaianne-Wolfer ME, Knight SW, Wyse DM.

J Nurses Prof Dev. 2019 Jan/Feb;35(1):18-24. doi: 10.1097/NND.0000000000000507.

PMID:
30608316
3.

Safe Patient Handling and Mobility: Development and Implementation of a Large-Scale Education Program.

Lee C, Knight SW, Smith SL, Nagle DJ, DeVries L.

Crit Care Nurs Q. 2018 Jul/Sep;41(3):253-263. doi: 10.1097/CNQ.0000000000000204.

PMID:
29851674
4.

Thrombus-in-Transit: A Case for a Multidisciplinary Hospital-Based Pulmonary Embolism System of Care.

Pappas AJ, Knight SW, McLean KZ, Bork S, Kurz MC, Sawyer KN.

J Emerg Med. 2016 Sep;51(3):298-302. doi: 10.1016/j.jemermed.2016.05.026. Epub 2016 Jun 25.

PMID:
27353058
5.

Peripheral Primitive Neuroectodermal Tumor and Neurofibromatosis Type 1 in an Adolescent Male.

Knight TE, Knight SW, Kyono W, Thompson K, Hicks J, Shiramizu B.

Pediatr Blood Cancer. 2016 Jul;63(7):1310-1. doi: 10.1002/pbc.25927. Epub 2016 Feb 1. No abstract available.

6.

Engineered zinc-finger transcription factors activate OCT4 (POU5F1), SOX2, KLF4, c-MYC (MYC) and miR302/367.

Ji Q, Fischer AL, Brown CR, Eastlund ER, Dvash T, Zhong B, Gerber MA, Lyons I, Knight SW, Kreader CA.

Nucleic Acids Res. 2014 Jun;42(10):6158-67. doi: 10.1093/nar/gku243. Epub 2014 May 3.

7.

RNA interference in marine and freshwater sponges: actin knockdown in Tethya wilhelma and Ephydatia muelleri by ingested dsRNA expressing bacteria.

Rivera AS, Hammel JU, Haen KM, Danka ES, Cieniewicz B, Winters IP, Posfai D, Wörheide G, Lavrov DV, Knight SW, Hill MS, Hill AL, Nickel M.

BMC Biotechnol. 2011 Jun 16;11:67. doi: 10.1186/1472-6750-11-67.

8.

Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.

Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I.

Blood. 2006 Apr 1;107(7):2680-5. Epub 2005 Dec 6.

9.

The role of RNA editing by ADARs in RNAi.

Knight SW, Bass BL.

Mol Cell. 2002 Oct;10(4):809-17.

10.
11.
12.

Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis.

Knight SW, Vulliamy TJ, Morgan B, Devriendt K, Mason PJ, Dokal I.

Hum Genet. 2001 Apr;108(4):299-303.

PMID:
11379875
13.

Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.

Vulliamy TJ, Knight SW, Mason PJ, Dokal I.

Blood Cells Mol Dis. 2001 Mar-Apr;27(2):353-7.

PMID:
11259155
14.

A link between RNA interference and nonsense-mediated decay in Caenorhabditis elegans.

Domeier ME, Morse DP, Knight SW, Portereiko M, Bass BL, Mango SE.

Science. 2000 Sep 15;289(5486):1928-31.

15.

Disruption of the Borrelia burgdorferi gac gene, encoding the naturally synthesized GyrA C-terminal domain.

Knight SW, Kimmel BJ, Eggers CH, Samuels DS.

J Bacteriol. 2000 Apr;182(7):2048-51.

16.

Mutation analysis of the DKC1 gene in incontinentia pigmenti.

Heiss NS, Poustka A, Knight SW, Aradhya S, Nelson DL, Lewis RA, Esposito T, Ciccodicola A, D'Urso M, Smahi A, Heuertz S, Munnich A, Vabres P, Woffendin H, Kenwrick S.

J Med Genet. 1999 Nov;36(11):860-2. No abstract available.

17.

Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1.

Knight SW, Heiss NS, Vulliamy TJ, Aalfs CM, McMahon C, Richmond P, Jones A, Hennekam RC, Poustka A, Mason PJ, Dokal I.

Br J Haematol. 1999 Nov;107(2):335-9.

PMID:
10583221
18.
19.

Dyskeratosis congenita caused by a 3' deletion: germline and somatic mosaicism in a female carrier.

Vulliamy TJ, Knight SW, Heiss NS, Smith OP, Poustka A, Dokal I, Mason PJ.

Blood. 1999 Aug 15;94(4):1254-60.

20.

X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.

Knight SW, Heiss NS, Vulliamy TJ, Greschner S, Stavrides G, Pai GS, Lestringant G, Varma N, Mason PJ, Dokal I, Poustka A.

Am J Hum Genet. 1999 Jul;65(1):50-8.

21.

Human hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) encoded at 1p36: coding sequence and expression.

Mason PJ, Stevens D, Diez A, Knight SW, Scopes DA, Vulliamy TJ.

Blood Cells Mol Dis. 1999 Feb;25(1):30-7.

PMID:
10349511
22.

1.4 Mb candidate gene region for X linked dyskeratosis congenita defined by combined haplotype and X chromosome inactivation analysis.

Knight SW, Vulliamy TJ, Heiss NS, Matthijs G, Devriendt K, Connor JM, D'Urso M, Poustka A, Mason PJ, Dokal I.

J Med Genet. 1998 Dec;35(12):993-6.

23.

X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions.

Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I.

Nat Genet. 1998 May;19(1):32-8.

PMID:
9590285
24.

Skewed X-inactivation in carriers of X-linked dyskeratosis congenita.

Vulliamy TJ, Knight SW, Dokal I, Mason PJ.

Blood. 1997 Sep 15;90(6):2213-6.

25.

The insulin gene region and susceptibility to insulin-dependent diabetes mellitus in four races; new insights from Afro-Caribbean race-specific haplotypes.

Mijovic CH, Penny MA, Jenkins D, Jacobs K, Heward J, Knight SW, Lucassen A, Morrison E, Barnett AH.

Autoimmunity. 1997;26(1):11-22.

PMID:
9556351
26.

Fine mapping of the dyskeratosis congenita locus in Xq28.

Knight SW, Vulliamy T, Forni GL, Oscier D, Mason PJ, Dokal I.

J Med Genet. 1996 Dec;33(12):993-5.

27.

HLA-DQB1 upstream regulatory region polymorphism and type I diabetes.

Knight SW, Mijovic C, Barnett AH.

Tissue Antigens. 1996 Mar;47(3):231-6. No abstract available.

PMID:
8740774
28.

RNA-protein interactions in the 5' untranslated region of preproinsulin mRNA.

Knight SW, Docherty K.

J Mol Endocrinol. 1992 Jun;8(3):225-34.

PMID:
1632895
29.

Metabolic control of insulin gene expression and biosynthesis.

Docherty K, Clark AR, Scott V, Knight SW.

Proc Nutr Soc. 1991 Dec;50(3):553-8. Review. No abstract available.

PMID:
1809963
30.

The identification of protein-RNA interactions within the 5' untranslated region of human preproinsulin mRNA.

Knight SW, Docherty K.

Biochem Soc Trans. 1991 Apr;19(2):120S. No abstract available.

PMID:
1909653
31.

The successful management of "refractory" ambulatory schizophrenic patients.

Knight SW, Donlon PT.

J Psychiatr Nurs Ment Health Serv. 1974 Jan-Feb;12(1):3-6. No abstract available.

PMID:
4362856
32.

A therapeutic aftercare setting for "refractory" chronic schizophrenic patients.

Donlon PT, Rada RT, Knight SW.

Am J Psychiatry. 1973 Jun;130(6):682-4. No abstract available.

PMID:
4349737
33.

Group rehabilitation in chronic schizophrenia.

Knight SW.

Nurs Times. 1967 Jul 21;63(29):964-5. No abstract available.

PMID:
6029085

Supplemental Content

Loading ...
Support Center